BioSpace News Archive

Vitls Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Vitls Platform. The Vitls Platform utilizes a single device to continuously and remotely monitor the vital signs clinicians need to assess the status of patients in multiple healthcare settings - from the hospi

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has initiated activities to penetrate European markets in order to offer a test based on its diagnostic platform to patients who suffer from cancer and a

Aphena Pharma Solutions, an industry-leading contract pharmaceutical manufacturing and packaging corporation, has announced the launch of its newly redesigned website, aphenapharma.com.

This new partnership will offer comprehensive pediatric surgical services for patients in the Tampa Bay community.

Ashion Analytics LLC announced today that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostic Services Program (MolDX), has awarded coverage to its proprietary cancer profiling test, GEM ExTra ®, one of the nation’s most comprehensive genomic cancer analysis tests. GEM ExTra , Ashion’s

VUNO Inc., South Korean artificial intelligence (AI) developer announced that it will attend the European Congress of Radiology 2020 (ECR 2020) to be held from July 15 to July 19, 2020 to showcase the power of its flagship AI radiology solutions that have recently received the CE mark. As part of its ambitious plan to go global, V

Ariadne Labs is pleased to announce Mary Brindle, MD, MPH, as the new Director of the Safe Surgery/Safe Systems Program, following an extensive international search.

AccuVein Inc., the global leader in vein visualization technology announced today two strategic hires: Kevin McArdle as Chief Financial Officer and Philip Spiegel as Chief Sales Officer

MAXAIR CAPR’s New Standard PAPR Filter will be in production early July, months ahead of schedule

NanoSurface Biomedical, a leading developer of human stem cell-based biotechnology products, today announced a comprehensive rebrand, including a change of the company’s name to Curi Bio (www.curibio.com).